SHSAX — BlackRock Health Sciences Opportunities Portfolio
Data updated: 2026-08-13
SHSAX — BlackRock Health Sciences Opportunities Portfolio. Holdings, fees, performance and SEC filings.
SHSAX Fund Overview
SHSAX — BlackRock Health Sciences Opportunities Portfolio is a US mutual fund managed by Blackrock Funds, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Blackrock Funds
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $5.91B
- 1-year return: 16.9%
- Ticker: SHSAX
- SEC CIK: 0000844779
- SEC series ID: S000001877
- Share class ID: C000004914
SHSAX Holdings
Top 10 holdings of BlackRock Health Sciences Opportunities Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Company | 12.29% |
| Johnson & Johnson | 8.77% |
| Unitedhealth Group, Inc. | 6.10% |
| Merck & Company, Inc. | 4.94% |
| Gilead Sciences, Inc. | 4.19% |
| Abbvie, Inc. | 3.94% |
| Amgen, Inc. | 3.37% |
| Thermo Fisher Scientific, Inc. | 3.02% |
| Vertex Pharmaceuticals, Inc. | 2.74% |
| Pfizer, Inc. | 2.61% |
SHSAX Portfolio Allocation
Asset-class allocation of BlackRock Health Sciences Opportunities Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.8% |
| Cash & Equivalents | 1.4% |
SHSAX Performance
Total returns for SHSAX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -2.6% |
| 1 year | 16.9% |
| 3 years (annualised) | 7.6% |
| 5 years (annualised) | 4.1% |
SHSAX Risk Information
Risk metrics for SHSAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.0%
SHSAX Costs and Fees
SHSAX costs about $109 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.09%
- Gross expense ratio: 1.09%
- Portfolio turnover: 43%
- Brokerage commissions: 1.96 bps of average net assets (SEC N-CEN)
SHSAX Cashflows
Over the 12 months to 2026-05, BlackRock Health Sciences Opportunities Portfolio had net outflows of $861.41M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-05 | −$96.69M |
| 2026-04 | −$135.37M |
| 2026-03 | −$72.13M |
| 2026-02 | −$81.94M |
| 2026-01 | −$76.61M |
| 2025-12 | $172.30M |
SHSAX Debt Constituents
No individual debt constituents are reported in BlackRock Health Sciences Opportunities Portfolio's latest SEC N-PORT filing.
SHSAX Prospectus and SEC Filings
Official BlackRock Health Sciences Opportunities Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2025-09-25
- Prospectus (485BPOS) — filed 2024-09-25
- Prospectus (485BPOS) — filed 2023-09-26
- Portfolio holdings (N-PORT) — filed 2026-07-27
- Portfolio holdings (N-PORT) — filed 2026-04-24
- Portfolio holdings (N-PORT) — filed 2026-01-26
- Annual census (N-CEN) — filed 2026-08-13
- Annual census (N-CEN) — filed 2025-08-11
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.